October 9, 2012
Takeda Pharmaceutical announced on October 5 that its subsidiary Takeda America Holdings has formed an agreement to acquire LigoCyte Pharmaceuticals (Bozeman, Montana), a US bioventure company specializing in the development of innovative vaccines. Its norovirus vaccine, currently in a clinical...read more